Education
About Us
Working with TipRanks
Follow Us
Pharming Group (NL:PHARM)
:PHARM
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 286.89M | $ 245.32M | $ 205.62M | $ 189.85M | $ 228.39M |
| Gross Profit | $ 252.72M | $ 220.10M | $ 188.06M | $ 169.67M | $ 203.06M |
| Operating Income | $ -8.32M | $ -4.88M | $ 18.23M | $ 27.84M | $ 82.09M |
| EBITDA | $ 7.19M | $ 9.88M | $ 33.53M | $ 48.78M | $ 92.11M |
| Net Income | $ -10.64M | $ -10.55M | $ 13.67M | $ 16.00M | $ 37.75M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 162.07M | $ 213.42M | $ 207.34M | $ 191.72M | $ 205.49M |
| Total Assets | $ 386.88M | $ 462.85M | $ 425.80M | $ 396.90M | $ 419.12M |
| Total Debt | $ 108.42M | $ 171.54M | $ 166.69M | $ 161.59M | $ 162.22M |
| Net Debt | $ 55.38M | $ 109.80M | $ -40.65M | $ -30.13M | $ -43.27M |
| Total Liabilities | $ 172.72M | $ 244.07M | $ 221.16M | $ 204.19M | $ 235.39M |
| Stockholders' Equity | $ 214.16M | $ 218.78M | $ 204.64M | $ 192.72M | $ 183.73M |
| Cash Flow | |||||
| Free Cash Flow | $ -2.59M | $ -18.77M | $ 20.92M | $ 20.17M | $ 74.51M |
| Operating Cash Flow | $ -1.79M | $ -17.30M | $ 22.90M | $ 36.13M | $ 90.98M |
| Investing Cash Flow | $ 31.62M | $ -129.39M | $ 5.32M | - | - |
| Financing Cash Flow | $ -34.41M | $ -1.04M | $ -4.98M | - | $ 65.33M |